OTC - ACTIVE INGREDIENT SECTION
Glycerin......8.24%
Glucomannan......0.20%
Collagen......0.15%
COLLAGEN EYE MASK
- Manufacturer
- COMFMET LIMITED
- Effective date
- 2024-10-23
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 1
- Source
- full-release
- Hydrated at
- 2026-06-01 00:28:47
Label at a glance#
ProductCOLLAGEN EYE MASK
Active ingredientHUMAN TYPE V COLLAGEN, GLUCOMANNAN, GLYCERIN
Label structure13 sections
Label contents#
Full prescribing information#
OTC - PURPOSE SECTION
Revitalize your under eye skin gold-infused Gold collagen Eye Mask that are remarkably refreshing and smoothing. Our gold eye masks gel pads are ultra gentle, safe, and dependable.
INDICATIONS & USAGE SECTION
1 .After washing your face, first use makeup water to soothe your skin.
2. Take out a piece of eye film and apply it around the eyes.
3. The effect of lying flat application is better. lt can be applied for 15-20 minutes.
4. After applying, take off the eye mask and gently massage until it is absorbed
WARNINGS SECTION
For external use only.
OTC - DO NOT USE SECTION
Do not use on damaged or broken skin.
OTC - WHEN USING SECTION
When using this product keep out of eyes. Rinse with water to remove.
OTC - STOP USE SECTION
Stop use and ask a doctor if rash occurs.
OTC - ASK DOCTOR SECTION
If skin rash occurs during or after use
OTC - KEEP OUT OF REACH OF CHILDREN SECTION
Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.
INACTIVE INGREDIENT SECTION
Aqua
Cl 77891
Cl 77019
Potassium chloride
Chondrus
Cl 77491
OTC - QUESTIONS SECTION
Email:commet515@gmail.com
DOSAGE & ADMINISTRATION SECTION
1 .After washing your face, first use makeup water to soothe your skin.
2. Take out a piece of eye film and apply it around the eyes.
3. The effect of lying flat application is better. lt can be applied for 15-20 minutes.
4. After applying, take off the eye mask and gently massage until it is absorbed
One patch for each eye at a time.
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
DailyMed Pharmacologic Classes#
| Class | Version | Type | Effective |
|---|---|---|---|
| GLYCERIN Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 84766-0006-1 | 2025-07-29 | C162847 | 48780-1 | 3b156c62-2f4c-fb37-e063-e6dba90a4e07 | 2522d6f4-1976-d51c-e063-6394a90a8c5e |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 84766-0006-1 | COLLAGEN EYE MASK | 6 g in 1 BAG | GEL | 6 | 1 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 84766-0006 | COLLAGEN EYE MASK GEL [COMFMET LIMITED] | 1 | 1 package rows | 20241025_2522d6f4-1976-d51c-e063-6394a90a8c5e.zip |
Products#
Every source-derived product name is available through these pages.
- COLLAGEN EYE MASK
- HUMAN TYPE V COLLAGEN
- TITANIUM DIOXIDE
- GLUCOMANNAN
- AQUA
- GLYCERIN
- POTASSIUM CHLORIDE
- .MU.-METHYLENE-.MU.-CHLOROBIS(.ETA.5-2,4-CYCLOPENTADIEN-1-YL)(DIMETHYLALUMINUM)TITANIUM
- MICA
- IRON OXIDES
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 84766-0006 | 84766-0006-1 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| HUMAN TYPE V COLLAGEN | K8J6GZ36BG | ACTIB |
| TITANIUM DIOXIDE | 15FIX9V2JP | IACT |
| GLUCOMANNAN | 36W3E5TAMG | ACTIB |
| AQUA | 059QF0KO0R | IACT |
| GLYCERIN | PDC6A3C0OX | ACTIB |
| POTASSIUM CHLORIDE | 660YQ98I10 | IACT |
| .MU.-METHYLENE-.MU.-CHLOROBIS(.ETA.5-2,4-CYCLOPENTADIEN-1-YL)(DIMETHYLALUMINUM)TITANIUM | V040SDB67S | IACT |
| MICA | V8A1AW0880 | IACT |
| IRON OXIDES | 1K09F3G675 | IACT |
Source Document#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 2522d6f4-1977-d51c-e063-6394a90a8c5e | 2522d6f4-1976-d51c-e063-6394a90a8c5e | 2024-10-23 | Warnings | 2522d6f4-1977-d51c-e063-6394a90a8c5e 2522d6f4-1976-d51c-e063-6394a90a8c5e |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.